Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis.

MLA

Salaffi, Fausto, et al. “Early Response to JAK Inhibitors on Central Sensitization and Pain Catastrophizing in Patients with Active Rheumatoid Arthritis.” Inflammopharmacology, vol. 30, no. 3, June 2022, pp. 1119–28. EBSCOhost, https://doi.org/10.1007/s10787-022-00995-z.

APA

Salaffi, F., Carotti, M., Farah, S., Ceccarelli, L., Giovagnoni, A., & Di Carlo, M. (2022). Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis. Inflammopharmacology, 30(3), 1119–1128. https://doi.org/10.1007/s10787-022-00995-z

Chicago

Salaffi, Fausto, Marina Carotti, Sonia Farah, Luca Ceccarelli, Andrea Giovagnoni, and Marco Di Carlo. 2022. “Early Response to JAK Inhibitors on Central Sensitization and Pain Catastrophizing in Patients with Active Rheumatoid Arthritis.” Inflammopharmacology 30 (3): 1119–28. doi:10.1007/s10787-022-00995-z.